These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. An experimental investigation of a novel iron chelating protoporphyrin IX prodrug for the enhancement of photodynamic therapy. Anayo L; Magnussen A; Perry A; Wood M; Curnow A Lasers Surg Med; 2018 Jul; 50(5):552-565. PubMed ID: 29603761 [TBL] [Abstract][Full Text] [Related]
25. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients. Fai D; Arpaia N; Romano I; Vestita M; Cassano N; Vena GA G Ital Dermatol Venereol; 2009 Jun; 144(3):281-5. PubMed ID: 19528909 [TBL] [Abstract][Full Text] [Related]
26. Monitoring the accumulation and dissipation of the photosensitizer protoporphyrin IX during standard dermatological methyl-aminolevulinate photodynamic therapy utilizing non-invasive fluorescence imaging and quantification. Tyrrell J; Campbell SM; Curnow A Photodiagnosis Photodyn Ther; 2011 Mar; 8(1):30-8. PubMed ID: 21333932 [TBL] [Abstract][Full Text] [Related]
27. Fluorescence characteristics and pharmacokinetic properties of a novel self-adhesive 5-ALA patch for photodynamic therapy of actinic keratoses. Fauteck JD; Ackermann G; Birkel M; Breuer M; Moor AC; Ebeling A; Ortland C Arch Dermatol Res; 2008 Feb; 300(2):53-60. PubMed ID: 17960406 [TBL] [Abstract][Full Text] [Related]
28. Photodynamic therapy using topically applied hypericin: comparative effect with methyl-aminolevulinic acid on UV induced skin tumours. Boiy A; Roelandts R; de Witte PA J Photochem Photobiol B; 2011 Feb; 102(2):123-31. PubMed ID: 21035351 [TBL] [Abstract][Full Text] [Related]
29. A quantitative comparison of 5-aminolaevulinic acid- and methyl aminolevulinate-induced fluorescence, photobleaching and pain during photodynamic therapy. Valentine RM; Ibbotson SH; Brown CT; Wood K; Moseley H Photochem Photobiol; 2011; 87(1):242-9. PubMed ID: 21077899 [TBL] [Abstract][Full Text] [Related]
30. An investigation of the fluorescence induced by topical application of 5-aminolaevulinic acid and methyl aminolaevulinate at different body sites on normal human skin. Lesar A; Ferguson J; Moseley H Photodiagnosis Photodyn Ther; 2011 Jun; 8(2):97-103. PubMed ID: 21497300 [TBL] [Abstract][Full Text] [Related]
31. Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulinic acid: implications for photodynamic treatment. Martin A; Tope WD; Grevelink JM; Starr JC; Fewkes JL; Flotte TJ; Deutsch TF; Anderson RR Arch Dermatol Res; 1995; 287(7):665-74. PubMed ID: 8534131 [TBL] [Abstract][Full Text] [Related]
32. Characteristics of 5-aminolaevulinic acid-induced protoporphyrin IX fluorescence in human skin in vivo. Ibbotson SH; Jong C; Lesar A; Ferguson JS; Padgett M; O'Dwyer M; Barnetson R; Ferguson J Photodermatol Photoimmunol Photomed; 2006 Apr; 22(2):105-10. PubMed ID: 16606416 [TBL] [Abstract][Full Text] [Related]
33. Aminolevulinic acid and methyl aminolevulinate equally effective in topical photodynamic therapy for non-melanoma skin cancers. Tarstedt M; Gillstedt M; Wennberg Larkö AM; Paoli J J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):420-3. PubMed ID: 26841041 [TBL] [Abstract][Full Text] [Related]
34. Protoporphyrin IX formation and photobleaching in different layers of normal human skin: methyl- and hexylaminolevulinate and different light sources. Togsverd-Bo K; Idorn LW; Philipsen PA; Wulf HC; Hædersdal M Exp Dermatol; 2012 Oct; 21(10):745-50. PubMed ID: 22882358 [TBL] [Abstract][Full Text] [Related]
35. A review of pain experienced during topical photodynamic therapy--our experience in Dundee. Attili SK; Dawe R; Ibbotson S Photodiagnosis Photodyn Ther; 2011 Mar; 8(1):53-7. PubMed ID: 21333935 [TBL] [Abstract][Full Text] [Related]
36. Topical methyl aminolevulinate. Siddiqui MA; Perry CM; Scott LJ Am J Clin Dermatol; 2004; 5(2):127-37; discussion 138-40. PubMed ID: 15109276 [TBL] [Abstract][Full Text] [Related]
37. Noninvasive fluorescence monitoring of protoporphyrin IX production and clinical outcomes in actinic keratoses following short-contact application of 5-aminolevulinate. Warren CB; Lohser S; Wene LC; Pogue BW; Bailin PL; Maytin EV J Biomed Opt; 2010; 15(5):051607. PubMed ID: 21054081 [TBL] [Abstract][Full Text] [Related]
38. Microscopic distribution of protoporphyrin (PpIX) fluorescence in superficial basal cell carcinoma during light-fractionated aminolaevulinic acid photodynamic therapy. de Haas ER; de Bruijn HS; Sterenborg HJ; Neumann HA; Robinson DJ Acta Derm Venereol; 2008; 88(6):547-54. PubMed ID: 19002337 [TBL] [Abstract][Full Text] [Related]
39. Correlation between treatment time, photobleaching, inflammation and pain after photodynamic therapy with methyl aminolevulinate on tape-stripped skin in healthy volunteers. Lerche CM; Fabricius S; Philipsen PA; Wulf HC Photochem Photobiol Sci; 2015 May; 14(5):875-82. PubMed ID: 25812618 [TBL] [Abstract][Full Text] [Related]
40. Kinetic fluorescence studies of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation in basal cell carcinomas. af Klinteberg C; Enejder AM; Wang I; Andersson-Engels S; Svanberg S; Svanberg K J Photochem Photobiol B; 1999 Apr; 49(2-3):120-8. PubMed ID: 10392462 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]